Foundation / Corporation
Israel Cancer Research Fund (ICRF)
01/17/18 11:59 PM ET Receipt
Grants providing a stipend of $35,000 per year to Israel early-career medical researchers affiliated with nonprofit institutions to support clinical or basic cancer research. Investigations must be conducted in Israel. The purpose of this program is to support young scientists who are in a formative career phase and who demonstrate exceptional potential for contributions to cancer research as investigators.
The awards are available for persons with research potential who need additional experience in a scientific environment that is conducive to the development of a career in independent research. The award is not intended for untried investigators or for those already established as independent investigators. The award is not intended simply to substitute one source of salary support for another for an individual who is already conducting full-time research, nor is it a mechanism for providing institutional support.
Because this funding opportunity targets development of early career investigators, it is important, and requisite, that a formal mentoring program be established for the investigator. There should be a primary mentor who should be available for guidance at all times. It is preferable that the primary mentor be at the same institution as the investigator. In addition, there should be a small mentoring committee formed of additional senior members who will meet with the investigators quarterly to evaluate progress and give guidance. All RCDA applications must include letters of support from the primary mentor and members of the mentoring committee.
Commitment to Research:
Individuals who receive an RCDA are to devote full-time to research and research-related activities. Such activities may include giving or receiving research training, supervising the research of others, participating in workshops and scientific or professional meetings, providing health care to the extent required to maintain clinical skills and expertise necessary for the conduct of research, and performing related academic activities that do not deter the awardee from accomplishing the purpose of the RCDA. The principal involvement must be with the actual conduct of research.
During the period of the award, the institution is expected to reduce or defer demands for teaching, service or committee duties that do not contribute directly to the development of the candidate's research career.
Allowable Award Costs:
The RCDA will reimburse the grantee institution for the employee's total efforts which, under the terms of the award, are to be devoted to full-time research and research-related activities. The RCDA may be used for salary or research costs incurred by the awardee, and the grantee institution may supplement the award consistent with the institution's salary scale.
The total salary proposed (ICRF and institutional contribution) must be based on a full-time, 12-month staff appointment. It must be consistent with both the established salary structure at the institution and with salaries actually provided by the institution from its own funds to other staff members of equivalent qualifications, rank and responsibilities in the department concerned. If full-time salaries are not currently paid to comparable staff members, the salary proposed must be appropriately related to the existing part-time salary structure.
The RCDA is made with the expectation that research support funds from the institution will be available to the awardee during the period of the award.
Funds may be requested for clinical or basic research, which must relate to cancer and must be conducted in Israel.
GrantWatch ID#: 138371
RCDAs award a stipend of $35,000 per year.
RCDAs are awarded, contingent upon the availability of funds, for a period of three (3) years.
Recipients are permitted and encouraged to reapply once for an additional three (3) years of support, provided that they are still within five (5) years of their first appointment to an independent position prior to the requested beginning date of the award.
Awards are activated September 1, 2018.
Funds for cancer research are available to citizens of Israel, both native-born and those who have settled. Funds are not available to visiting scientists. (Proof of Israeli citizenship must be furnished upon request.)
Relationship to Institution:
Although individuals are considered as the awardee, awards are made to eligible institutions on behalf of the awardee. The awardee is an employee of the institution to which the award is made and his or her status, title, salary and staff privileges are determined by the institution according to its established policies for individuals holding 12-month appointments, except as otherwise set out in this statement.
1. Nomination by Institution
Candidates must be nominated by a public or private nonprofit institution engaged in health- related research and located in Israel. The application must originate jointly with the institution and the proposed nominee, and must describe fully all proposed research and teaching activities. The endorsement (signature) of the head of the institution or other person authorized to commit the institution to abide by the requirements of the ICRF is required.
Candidates must have a doctoral degree, at least three (3) years of postdoctoral fellowship or equivalent experience, and be within five (5) years of their first appointment to an independent position prior to the requested beginning date of the award. An individual who has achieved professional recognition, as evidenced by substantial independent research accomplishments, significant number of publications of high quality in scientific or professional journals, or the attainment of senior faculty or equivalent status, is considered to have achieved the objective of this program and to be ineligible.
3. Concurrent Applications
An RCDA application may not be submitted concurrently with another research career development-type application that would duplicate the provisions of the RCDA. Other development awards considered to be duplicative include clinical investigator awards, academic and teacher investigator awards, and postdoctoral and senior fellowships.
The application deadline is January 17, 2018, at 11:59 PM ET.
-Application Received by the Fund in New York: January 17, 2018
-Notification of Decision: July 1, 2018
-Activation of Award: September 1, 2018
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Register to apply:
Ellen T. Rubin, Director, Research Grants
Israel Cancer Research Fund
52 Vanderbilt Avenue, Suite 1510
New York, NY 10017-3834